Cullinan Therapeutics, Inc.β―(Nasdaq: CGEM) is a biopharmaceutical company dedicated to creating new standards of care for patients.We have strategically built a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune disease. Our portfolio encompasses a wide range of modalities,...